top of page

"Think of all the beauty still left 

around you

and be happy"

About us

Sapphire Appearance Medicine| Auckland’s Doctor-Led Cosmetic Excellence

 

Located within Freemans Bay in Central Auckland, Sapphire Appearance Medicine Clinic is a premier destination for non-surgical aesthetic treatments. Every procedure at our clinic is performed by doctors with Dr. Garsing Wong and Dr. Thomas Doo being the first New Zealand-born and trained physicians to offer hair transplantation in the country.

 

Our Specialised Treatments

We combine medical precision with an artistic eye to deliver natural-looking results. Our core expertise includes:

  • Precision Injectables: Expert administration of Botox® for frown lines and crows feet, often combined with advanced dermal fillers such as Restylane Lyft®, Refyne, and Teoxane Teosyal Redensity I®.

  • Regenerative Therapies: Specialist providers of Sculptra®, Platelet Rich Plasma (PRP), and Venus Viva® Radiofrequency.

  • Body Contouring & Weight Loss: Home to the first Cooltech® Cocoon Cryolipolysis device in NZ and official providers of Wegovy® medical weight loss management.

  • NZ Hair Transplantation Institute: Co-located within our clinic at our purpose-built surgical suite, we provide shaved and long-hair FUE hair restoration.

 

Patient Note: Consultations are conducted in person located next to Good Boy Billy Cafe in Ponsonby/Auckland Central. To book your consultation, call 09 360 0066.

 

Medical Weight Management (WEGOVY®)

We offer Wegovy® (semaglutide), an injectable prescription medicine for chronic weight management. Clinical indications for treatment with Wegovy® include:

  • Asian Ethnicities: Indicated for those with a BMI over 28.

Other Ethnicities: Indicated for those with a BMI over 30 (or over 27 with weight-related medical problems).

​

WEGOVY® (semaglutide) injection 2.4 mg is an injectable self funded ie not subsidised prescription medicine used with a reduced calorie diet and increased physical activity:  Doctors fees are in addition to the medication cost

  • to reduce the risk of major cardiovascular events such as death, heart attack, or stroke in adults with known heart disease and with either obesity or overweight.

  • that may help adults and children aged 12 years and older with obesity, or some adults with overweight who also have weight-related medical problems, to help them lose excess body weight and keep the weight off. Full information on the bottom of this page

​

Meet The Team

Dr Garsing Wong

Dr Garsing Wong

Dr Thomas Doo

Dr Thomas Doo

Dr Margaret Chen

Margaret Chen

Dr. Garsing Wong | Specialist Hair Restoration & Appearance Medicine Physician

 

The New Zealand Authority in Hair Restoration

Dr. Garsing Wong is a pioneering figure in New Zealand’s medical aesthetic landscape. He is distinguished as the first New Zealand-born and trained physician to offer hair transplantation and has been appointed as a Subject Matter Expert by the American Board of Hair Restoration Surgery (ABHRS).

 

Dr. Wong remains the only hair restoration surgeon in the country recognised as a Diplomate of the ABHRS. This prestigious global certification is awarded to those who demonstrate the highest level of proficiency in both extensive written and oral examinations, each of which is statistically validated to ensure the highest standards of safety, proficiency, and aesthetic sensitivity. Furthermore, he serves as an Ambassador for Patient Safety, an appointment granted by the International Society of Hair Restoration Surgery (ISHRS).

 

Academic & Clinical Leadership

Beyond his practice at Sapphire Appearance Medicine, Dr. Wong is committed to elevating medical standards through academic and regulatory leadership:

  • University of Auckland: Honorary Senior Clinical Lecturer in the Department of General Practice and Primary Health Care, Faculty of Medical & Health Sciences.

  • Medical Examiner: Serves as an examiner for the Royal New Zealand College of Urgent Care Physicians, the ABHRS, and the New Zealand Society of Cosmetic Medicine.

  • Global Membership: Long-standing member of the International Society of Hair Restoration Surgery (Chicago).

 

Global Expertise & Fellowships

Born in Auckland and a graduate of the University of Auckland (BHB, MBChB), Dr. Wong’s medical background includes extensive international experience in the United Kingdom and Switzerland. He holds fellowships in three major colleges:

  • Fellow of the New Zealand College of Appearance Medicine

  • Fellow of the Royal New Zealand College of General Practitioners

  • Fellow of the College of Urgent Care Physicians

 

Comprehensive Aesthetic Medicine & Clinical Governance

With advanced training in Laser Medicine (University of Queensland) and an Advanced Certificate in the Principles and Practice of Radiochemistry (University of Auckland), Dr. Wong applies a rigorous scientific approach to aesthetics. Combined with his background in Community Emergency Medicine, he provides a level of clinical governance that ensures patient safety is at the forefront of every cosmetic treatment, from advanced injectables to complex surgical hair restoration.

 

Multilingual Consultations

To support Auckland’s diverse community, Dr. Wong offers full clinical consultations in:

  • English

  • Cantonese (粵語)

  • Mandarin (普通话)

  • German (Deutsch)


Present Positions: 

Diplomate of the American Board of Hair Restoration Surgery.

Member of the World FUE Institute - Hair Transplantation Institute, Belgium.

Member of the International Society of Hair Restoration Surgery, Chicago, USA.

Honorary Senior Clinical Lecturer - Department of General Practice and Primary Health Care, Faculty of Medical and Health Sciences, University of Auckland.

Fellow of the New Zealand College of Appearance Medicine, Fellow of the College of Urgent Care Physicians (formerly known as the Accident and Medical Practitioners Association), Fellow of the Royal New Zealand College of General Practitioners, Member of the International Hyperhidrosis Society. Registered with New Zealand Medical Council and the General Medical Council, United Kingdom.

Examiner for the Royal New Zealand College of Urgent Care Physicians - Urgent Care Physicians Exam since 2006 

Committee Member of the Clinical Effectiveness Group, Auckland Primary Health Organisation since 2017

 

Past Positions:
Former Censor for the New Zealand College of Appearance Medicine 2012-2013
Former Secretary and Treasurer of the New Zealand College of Appearance Medicine 2010-2012 
Former Chairman of the Royal New Zealand College of Urgent Care Physicians (prev. known as The Accident and Medical Practitioners Association)
Former Medical Director of West Auckland White Cross Accident and Medical Clinic, Henderson, Auckland.
Former Professional Member of the International Association for Organotherapy and Stem Cell Transplantation, Switzerland
Former Member of the Primary Care Advisory Group - Ministry of Social Development New Zealand 2007-2012
Former Member of the Network Lipolysis
Former Associate Member of the Australasian College of Phlebology
Former Medical Director of the White Cross West Auckland Accident and Medical Clinic 1996-1999
Worked in Worthing, Southlands, Orpington and Medway Hospital in England, United Kingdom. General Surgery and General Medicine in Regionalspital Thun, Switzerland.

​

​

Dr Thomas Doo, born in Auckland and a graduate of the University of Auckland, holds degrees in Medicine, Law, and Accounting. After attending Kings College in Otahuhu, Dr Doo was awarded a University Junior Scholarship to pursue studies at the School of Medicine, University of Auckland. Currently, Dr Doo resides and practices full-time in Auckland.

Dr Doo has Degrees in Law Commerce and post graduate diploma in Community Emergency Medicine, from Auckland University, and was admitted to the bar in 1996.   With qualifications as both a doctor and a lawyer, Dr Doo is a valuable asset to the field.​

​

​​​​Dr Doo is a full member of the ISHRS (International Society for Hair Restoration Surgery) and The World FUE Institute. Additionally, Dr Doo is recognised as a Fellow of the Royal New Zealand College of General Practitioners.Dr Doo shares a deep passion for hair transplants and, alongside Dr Wong, became the first New Zealand-born and locally qualified doctors to introduce permanent FUE (Follicular Unit Extraction) hair transplant surgery to New Zealand.

​

Languages spoken: English

 

​

(Margaret) Wen-Pei CHEN, Born in Taiwan, graduated from the University of Auckland with Bachelor of Science 1993, and Doctor of Medicine 1999 from The Peking Union Medical College, Beijing. Thesis completed on Malaria Vaccine Research. Laser Training Course, University of Queensland 2005.  Member of the New Zealand Cosmetic Toiletry and Fragrance Association trading as Cosmetic New Zealand.

 

Past Position:  Former Professional Member of the International Association for Organotherapy and Stem Cell Transplantation, Switzerland. Former Executive Member of the New Zealand Cosmetic Toiletry and Fragrance Association trading as Cosmetic New Zealand.

​​

Margaret regularly attends international cosmetic and appearance medicine conferences together with Dr Garsing Wong. Margaret Chen is the first person in New Zealand to gain experience in treating acne scarring, skin resurfacing and wrinkle reduction using the Palomar Non-Ablative Fractional 1540nM Erbium:Glass laser and the first to offer the innovative Venus Viva Nanofractional Ablative Radiofrequency device together with the Venus Viva Diamond Polar skin tightening device. Together with Dr Garsing Wong, Margaret Chen has given workshops for Dermatologist and Plastic Surgeons at the 6th Anti-Aging Symposium in Taiwan, October 2007.​

 

Margaret has formulated her own advanced skin care range Monalinda which is showcased in her Fat Freezing Clinic - Coolbody, assisted by Yvonne Marvin, practice manager of Coolbody and personal trainer.​

 

Languages spoken: English, Mandarin, Taiwanese.

​

Updated 19 February 2026​

​

​

​

​

​

American Board of Hair Restoration Surgery
International Society of Hair Restoration Surgery
Media

Press Coverage

 

Mind Food 23/Sep/2010

My Wedding Summer 2010/11 Nonsurgical Breast Enhancement

Phosphatidylcholine & Botox Facial Shaping published in the Journal of Cosmetic Dermatology

Never miss an update

Join our mailing list

Sapphire Appearance Medicine Clinic

Address: 26 College Hill,

Freemans Bay,  Auckland 1011

Phone: 09-360 0066

Email: sapphireclinic@gmail.com

  • Facebook Social Icon
  • Twitter Social Icon
  • Instagram Social Icon

MANDATORY STATEMENTS FOR ADVERTISING :

1) BOTOX® is a prescription medicine for the treatment of frown lines , horizontal forehead lines and crow’s feet round the eyes. Botox® has risks and benefits. Ask your doctor if Botox is right for you. If you have side effects, see your doctor. You will need to pay for Botox® and clinic fees will apply. For details on precautions & side effects consult your healthcare professional or the Consumer Medicine Information (CMI) at www.medsafe.govt.nz . Botox® treatment lasts about 4 months and further courses of treatment may be necessary. Should only be administered by trained medical professionals. (contains botulinum toxin A 50,100 & 200 units) Allergan (NZ) Limited, Auckland.

​2) TEOSYAL RHA® 1, TEOSYAL RHA® 2, TEOSYAL RHA® 3, TEOSYAL RHA® 4, TEOSYAL® PURESENSE REDENSITY 1, TEOSYAL® PURESENSE REDENSITY 2, TEOSYAL PURESENSE KISS ® , TEOSYAL® PURESENSE GLOBAL ACTION, TEOSYAL® PURESENSE DEEP LINES, TEOSYAL® PURESENSE ULTIMATE and TEOSYAL® PURESENSE ULTRA DEEP TEOSYAL KISS® , RHA KISS® , TEOSYAL® MESO, TEOSYAL® GLOBAL ACTION, TEOSYAL® DEEP LINES, , TEOSYAL® ULTIMATE and TEOSYAL® ULTRA DEEP are trademark of the firm TEOXANE SA. These products are gel that contains hyaluronic acid, and 0.3% by weight of lidocaine hydrochloride They are class III medical devices. Caution for people on blood thinning medicines. Local side effects: inflammatory reactions (redness, oedema, pain at the point of injection), haematomas, itching, temporary loss of sensitivity around the injected area, disorders of pigmentation in skin and hair, abscesses, indurations, nodules (possibly granulomas). General manifestations: immediate hypersensitivity up to anaphylactic shock, migration of the implant. Rare but serious adverse events associated with the intravascular injection of soft tissue fillers in the face have been reported and include temporary or permanent vision impairment or blindness, skin necrosis and stroke. Lasts 9 -12 months. Please consult your doctor pharmacist for more information. Please refer to instructions for use, local distributor. Healthcare Logistics, Auckland.

3) BELKYRA® injection is a prescription medicine containing 10 mg/mL deoxycholic acid. It is used for the improvement in the appearance of moderate to severe convexity or fullness associated with fat below the jaws in adults. Do not use in people allergic to this medicine, with infection at site of injection, pregnancy, and lactation. Possible side effects include headaches, difficulty swallowing, nausea, skin tightness, hypertension, injection site bruising/pain/swelling/numbness/redness/tingling/hardness/itching /discolouration/formation of small areas of hardness/warmth and injection site nerve injury. BELKYRA® treatment is not funded on the New Zealand Pharmaceutical Schedule. You will need to pay for this medicine. Normal Doctors visit fees apply. BELKYRA® treatment should be administered only by trained medical professionals. Speak to your specialist about your own situation and about the benefits/risks of this procedure in appearance medicine. For further information, the Data Sheet and Consumer Medicines Information can be accessed at www.medsafe.govt.nz or ask your doctor. If you have any side effects or concerns speak to your doctor. Note: Results from BELKYRA® treatment usually last up to 4 years. Allergan New Zealand Limited, Auckland.

4)  Restylane® is a gel containing hyaluronic acid and lidocaine that is injected by a healthcare professional into or below the skin to smooth facial wrinkles and enhance lips by restoring volume and fullness. Restylane is a Class III medical device and has risks and benefits. Restylane® treatment may result in some redness, swelling, pain or tenderness, itching and/or bruising which may last a few days. Inflammatory reactions can begin up to two to four weeks after treatment in rare cases. See your healthcare professional if any side effects concern you. Exposure to excessive sunlight or extreme cold should be avoided until redness or swelling has resolved. Restylane® should not be used in an area where there is a nonresorbable implant or in irritated or infected skin, Restylane® should not be used in people taking blood thinning medicines or who have an allergy to hyaluronic acid, lidocaine or other local anaesthetics. Caution if you take medicines that prolong bleeding time. Treatment lasts 12-24 months. Restylane has not been tested in pregnant or breast-feeding women. ALWAYS FOLLOW THE INSTRUCTIONS YOU ARE GIVEN. Galderma, Auckland. Distributed by Healthcare Logistics, Auckland

5) Restylane® Skinboosters is a gel containing hyaluronic acid that is injected into or below the skin to improve skin structure, hydration and elasticity. Restylane® Skinboosters is a medical device class III that has risks and benefits. Do not use in patients with bleeding disorders, or in patients taking blood thinning medicines. Do not inject intravascularly, where there is active disease, inflammation, infection, or tumours near the intended treatment site Possible side effects are injection site effects like swelling, bruising, and tenderness and inflammation. Treatment usually lasts 6-12 months. Product and treatment costs will apply. Consult your cosmetic practitioner for further information. Further product details can also be found in the full product information. Galderma, Auckland.

 

BOTOX® is a registered trademark of Allergan Inc.

Teosyal Global Action, Teosyal Ultimate, Teosyal Redensity I and II® are registered trademarks of Teoxane, Geneva, Switzerland.

​Belkyra® is a Prescription Medicine used to reduce submental fat (double chin region).  Belkyra® is a Prescription Medicine used to reduce submental fat (double chin region) is a registered trademark of Allergan Inc.

​

Mandatories:WEGOVY® (semaglutide) injection 2.4 mg is an injectable self funded ie not subsidised prescription medicine used with a reduced calorie diet and increased physical activity:  Doctors fees are in addition to the medication costto reduce the risk of major cardiovascular events such as death, heart attack, or stroke in adults with known heart disease and with either obesity or overweight.that may help adults and children aged 12 years and older with obesity, or some adults with overweight who also have weight-related medical problems, to help them lose excess body weight and keep the weight off. Full information on the bottom of this page. Wegovy® contains semaglutide and should not be used with other semaglutide-containing products or other GLP-1 receptor agonist medicines.It is not known if Wegovy® is safe and effective for use in children under 12 years of age.Wegovy® may cause serious side effects, including:Possible thyroid tumors, including cancer. Tell your healthcare provider if you get a lump or swelling in your neck, hoarseness, trouble swallowing, or shortness of breath. These may be symptoms of thyroid cancer. In studies with rodents, Wegovy® and medicines that work like Wegovy® caused thyroid tumors, including thyroid cancer. It is not known if Wegovy® will cause thyroid tumors or a type of thyroid cancer called medullary thyroid carcinoma (MTC) in peopleDo not use Wegovy® if you or any of your family have ever had a type of thyroid cancer called medullary thyroid carcinoma (MTC) or if you have an endocrine system condition called Multiple Endocrine Neoplasia syndrome type 2 (MEN 2) Do not use Wegovy® if:you or any of your family have ever had a type of thyroid cancer called medullary thyroid carcinoma (MTC) or if you have an endocrine system condition called Multiple Endocrine Neoplasia syndrome type 2 (MEN 2)you have had a serious allergic reaction to semaglutide or any of the ingredients in Wegovy® Before using Wegovy®, tell your healthcare provider if you have any other medical conditions, including if you:have or have had problems with your pancreas or kidneyshave type 2 diabetes and a history of diabetic retinopathyhave or have had depression, suicidal thoughts, or mental health issuesare scheduled to have surgery or other procedures that use anesthesia or deep sleepiness (deep sedation)are pregnant or plan to become pregnant. Wegovy® may harm your unborn baby. You should stop using Wegovy® 2 months before you plan to become pregnantare breastfeeding or plan to breastfeed. It is not known if Wegovy® passes into your breast milkTell your healthcare provider about all the medicines you take, including prescription and over-the-counter medicines, vitamins, and herbal supplements. Wegovy® may affect the way some medicines work and some medicines may affect the way Wegovy® works. Tell your healthcare provider if you are taking other medicines to treat diabetes, including sulfonylureas or insulin. Wegovy® slows stomach emptying and can affect medicines that need to pass through the stomach quickly.Wegovy® may cause serious side effects, including:Possible thyroid tumors, including cancer. Tell your healthcare provider if you get a lump or swelling in your neck, hoarseness, trouble swallowing, or shortness of breath. These may be symptoms of thyroid cancer. In studies with rodents, Wegovy® and medicines that work like Wegovy® caused thyroid tumors, including thyroid cancer. It is not known if Wegovy® will cause thyroid tumors or a type of thyroid cancer called medullary thyroid carcinoma (MTC) in peopleDo not use Wegovy® if you or any of your family have ever had a type of thyroid cancer called medullary thyroid carcinoma (MTC) or if you have an endocrine system condition called Multiple Endocrine Neoplasia syndrome type 2 (MEN 2) Do not use Wegovy® if:you or any of your family have ever had a type of thyroid cancer called medullary thyroid carcinoma (MTC) or if you have an endocrine system condition called Multiple Endocrine Neoplasia syndrome type 2 (MEN 2)you have had a serious allergic reaction to semaglutide or any of the ingredients in Wegovy® Before using Wegovy®, tell your healthcare provider if you have any other medical conditions, including if you:have or have had problems with your pancreas or kidneyshave type 2 diabetes and a history of diabetic retinopathyhave or have had depression, suicidal thoughts, or mental health issuesare scheduled to have surgery or other procedures that use anesthesia or deep sleepiness (deep sedation)are pregnant or plan to become pregnant. Wegovy® may harm your unborn baby. You should stop using Wegovy® 2 months before you plan to become pregnantare breastfeeding or plan to breastfeed. It is not known if Wegovy® passes into your breast milkTell your healthcare provider about all the medicines you take, including prescription and over-the-counter medicines, vitamins, and herbal supplements. Wegovy® may affect the way some medicines work and some medicines may affect the way Wegovy® works. Tell your healthcare provider if you are taking other medicines to treat diabetes, including sulfonylureas or insulin. Wegovy® slows stomach emptying and can affect medicines that need to pass through the stomach quickly. What are the possible side effects of Wegovy®?Wegovy® may cause serious side effects, including:inflammation of your pancreas (pancreatitis). Stop using Wegovy® and call your healthcare provider right away if you have severe pain in your stomach area (abdomen) that will not go away, with or without vomiting. You may feel the pain from your abdomen to your backgallbladder problems. Wegovy® may cause gallbladder problems, including gallstones. Some gallstones may need surgery. Call your healthcare provider if you have symptoms, such as pain in your upper stomach (abdomen), fever, yellowing of the skin or eyes (jaundice), or clay-colored stoolsincreased risk of low blood sugar (hypoglycemia), especially those who also take medicines for diabetes such as insulin or sulfonylureas. This can be a serious side effect. Talk to your healthcare provider about how to recognize and treat low blood sugar and check your blood sugar before you start and while you take Wegovy®. Signs and symptoms of low blood sugar may include dizziness or light-headedness, blurred vision, anxiety, irritability or mood changes, sweating, slurred speech, hunger, confusion or drowsiness, shakiness, weakness, headache, fast heartbeat, or feeling jitterykidney problems (kidney failure). In people who have kidney problems, diarrhea, nausea, and vomiting may cause a loss of fluids (dehydration), which may cause kidney problems to get worse. It is important for you to drink fluids to help reduce your chance of dehydrationsevere stomach problems. Stomach problems, sometimes severe, have been reported in people who use Wegovy®. Tell your healthcare provider if you have stomach problems that are severe or will not go awayserious allergic reactions. Stop using Wegovy® and get medical help right away, if you have any symptoms of a serious allergic reaction, including swelling of your face, lips, tongue, or throat; problems breathing or swallowing; severe rash or itching; fainting or feeling dizzy; or very rapid heartbeatchange in vision in people with type 2 diabetes. Tell your healthcare provider if you have changes in vision during treatment with Wegovy®increased heart rate. Wegovy® can increase your heart rate while you are at rest. Tell your healthcare provider if you feel your heart racing or pounding in your chest and it lasts for several minutesdepression or thoughts of suicide. You should pay attention to any mental changes, especially sudden changes in your mood, behaviors, thoughts, or feelings. Call your healthcare provider right away if you have any mental changes that are new, worse, or worry youfood or liquid getting into the lungs during surgery or other procedures that use anesthesia or deep sleepiness (deep sedation). Wegovy® may increase the chance of food getting into your lungs during surgery or other procedures. Tell all your healthcare providers that you are taking Wegovy® before you are scheduled to have surgery or other procedures The most common side effects of Wegovy® may include: nausea, diarrhea, vomiting, constipation, stomach

(abdomen) pain, headache, tiredness (fatigue), upset stomach, dizziness, feeling bloated, belching, low blood sugar in people with type 2 diabetes, gas, stomach flu, heartburn, and runny nose or sore throat.

bottom of page